Massimo S Fiandaca

9PUBLICATIONS
16CO-AUTHORS
Gene and molecular therapyTransgenesisMolecular targetsRehabilitationColloid and surface chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 06, 2026
Clinical GDNF delivery methods for Parkinson's disease.

|Sep 11, 2025
Bilateral Putaminal Convection of Adeno-Associated Virus Vector Serotype 2 Glial Cell Line-Derived Neurotrophic Factor Gene Therapy in Parkinson's Disease May Provide Glial Cell Line-Derived Neurotrophic Factor Transgene Expression to Caudate Nucleus: Potential Role of Perivascular and Other Low Resistance Leakage Pathways.

Vikas Munjal, Asad S Akhter, Matthew T Rocco

|Feb 17, 2025
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop.

Roger A Barker, Mart Saarma, Clive N Svendsen

|Jun 20, 2020
Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders.

Massimo S Fiandaca, Russell R Lonser, J Bradley Elder

|Feb 09, 2020
Author Correction: Plasma microRNA markers of upper limb recovery following human stroke.

Matthew A Edwardson, Xiaogang Zhong, Massimo S Fiandaca

|May 03, 2019
Response to "Technical approaches to reduce interference of Fetal calf serum derived RNA in the analysis of extracellular vesicle RNA from cultured cells".

Brandon M Lehrich, Yaxuan Liang, Massimo S Fiandaca

Pageof 2

Frequent Collaborators

2 joint publications

Matthew A Edwardson

2 joint publications

Brandon M Lehrich

2 joint publications

Matthias Luz

2 joint publications

Krystof S Bankiewicz